Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019-A Multicenter, Open, Randomized Controlled Study

NCT04334265 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04334265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019-A Multicenter, Open, Randomized Controlled Study
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2020
Completion date
December 1, 2020
Enrollment
750 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19